Grant: Summer Program in Aging
Sunnybrook Research Institute (Toronto, Ontario)
$0.00
Summer Program in Aging 2022 on Neurodegenerative and Cerebrovascular Disease
EF 2021-22
Résumé
Dementia and cerebrovascular disease can lead to significant impact on everyday activities. The risk of dementia and cerebrovascular disease are linked to several chronic medical conditions emerging in midlife, such as hypertension and type 2 diabetes. Because current treatments for dementia and cerebrovascular disease are not considered efficacious, it is important to identify effective preventative strategies, especially in populations at a higher risk. There are many treatment choices for hypertension and type 2 diabetes, but these medications lower blood pressure or blood sugar via different mechanisms, and some medications may be more beneficial to the brain than the others. I am interested in the effects of different medications on aging-related outcomes, including time to dementia diagnosis or a stroke event. The aim of my research is to determine which treatments are better choices overall, as well as in certain subgroup of people, when these long-term aging-related outcomes are considered.
Programme
Summer Program in Aging
Bénéficiaire
Emplacement
Ontario, Canada
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
460496
Name
Wu Che-Yuan
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Clinical
Prcname2
Summer Program in Aging
Projecttitle
Summer Program in Aging 2022 on Neurodegenerative and Cerebrovascular Disease
Programtype2
Undefined
Orgnameinp2
Sunnybrook Research Institute (Toronto, Ontario)
Cihramount2
$0
Cihrequipment2
$0
Programname2
Summer Program in Aging
Keyworddelim
Aging; Dementia; Diabetes; Epidemiology; Hypertension; Medications; Stroke
Abstract
Dementia and cerebrovascular disease can lead to significant impact on everyday activities. The risk of dementia and cerebrovascular disease are linked to several chronic medical conditions emerging in midlife, such as hypertension and type 2 diabetes. Because current treatments for dementia and cerebrovascular disease are not considered efficacious, it is important to identify effective preventative strategies, especially in populations at a higher risk. There are many treatment choices for hypertension and type 2 diabetes, but these medications lower blood pressure or blood sugar via different mechanisms, and some medications may be more beneficial to the brain than the others. I am interested in the effects of different medications on aging-related outcomes, including time to dementia diagnosis or a stroke event. The aim of my research is to determine which treatments are better choices overall, as well as in certain subgroup of people, when these long-term aging-related outcomes are considered.
Competitiondate
202201
Approvedterm2
1 yr 0 mth
Pinamesdelim
Wu, Che-Yuan
Approvedterm
1 an 0 mois